$PTHS Q2 '26 Earnings Results & Recap Pelthos Therapeutics Inc. reported net product revenues of $15.4 million for the three months ended June 30, 2026, and $26.1 million for the six months ended June 30, 2026.
$PTHS Q2 '26 Earnings Results & Recap Pelthos Therapeutics Inc. reported net product revenues of $15.4 million for the three months ended June 30, 2026, and $26.1 million for the six months ended June 30, 2026.